Global Oral Contraceptive Market Insights and Forecast to 2028

Global Oral Contraceptive Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Oral Contraceptive Product Introduction
1.2 Market by Type
1.2.1 Global Oral Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Combination
1.2.3 Progestin Only
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oral Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Male
1.3.3 Female
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Contraceptive Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Contraceptive Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Contraceptive Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Contraceptive Sales by Region
2.4.1 Global Oral Contraceptive Sales by Region (2017-2022)
2.4.2 Global Sales Oral Contraceptive by Region (2023-2028)
2.5 Global Oral Contraceptive Revenue by Region
2.5.1 Global Oral Contraceptive Revenue by Region (2017-2022)
2.5.2 Global Oral Contraceptive Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Contraceptive Sales by Manufacturers
3.1.1 Global Top Oral Contraceptive Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Contraceptive Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Contraceptive in 2021
3.2 Global Oral Contraceptive Revenue by Manufacturers
3.2.1 Global Oral Contraceptive Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Contraceptive Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Contraceptive Revenue in 2021
3.3 Global Oral Contraceptive Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Contraceptive Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Contraceptive Sales by Type
4.1.1 Global Oral Contraceptive Historical Sales by Type (2017-2022)
4.1.2 Global Oral Contraceptive Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Contraceptive Sales Market Share by Type (2017-2028)
4.2 Global Oral Contraceptive Revenue by Type
4.2.1 Global Oral Contraceptive Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Contraceptive Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Contraceptive Revenue Market Share by Type (2017-2028)
4.3 Global Oral Contraceptive Price by Type
4.3.1 Global Oral Contraceptive Price by Type (2017-2022)
4.3.2 Global Oral Contraceptive Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Contraceptive Sales by Application
5.1.1 Global Oral Contraceptive Historical Sales by Application (2017-2022)
5.1.2 Global Oral Contraceptive Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Contraceptive Sales Market Share by Application (2017-2028)
5.2 Global Oral Contraceptive Revenue by Application
5.2.1 Global Oral Contraceptive Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Contraceptive Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Contraceptive Revenue Market Share by Application (2017-2028)
5.3 Global Oral Contraceptive Price by Application
5.3.1 Global Oral Contraceptive Price by Application (2017-2022)
5.3.2 Global Oral Contraceptive Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Contraceptive Market Size by Type
6.1.1 North America Oral Contraceptive Sales by Type (2017-2028)
6.1.2 North America Oral Contraceptive Revenue by Type (2017-2028)
6.2 North America Oral Contraceptive Market Size by Application
6.2.1 North America Oral Contraceptive Sales by Application (2017-2028)
6.2.2 North America Oral Contraceptive Revenue by Application (2017-2028)
6.3 North America Oral Contraceptive Market Size by Country
6.3.1 North America Oral Contraceptive Sales by Country (2017-2028)
6.3.2 North America Oral Contraceptive Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oral Contraceptive Market Size by Type
7.1.1 Europe Oral Contraceptive Sales by Type (2017-2028)
7.1.2 Europe Oral Contraceptive Revenue by Type (2017-2028)
7.2 Europe Oral Contraceptive Market Size by Application
7.2.1 Europe Oral Contraceptive Sales by Application (2017-2028)
7.2.2 Europe Oral Contraceptive Revenue by Application (2017-2028)
7.3 Europe Oral Contraceptive Market Size by Country
7.3.1 Europe Oral Contraceptive Sales by Country (2017-2028)
7.3.2 Europe Oral Contraceptive Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Contraceptive Market Size by Type
8.1.1 Asia Pacific Oral Contraceptive Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Contraceptive Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Contraceptive Market Size by Application
8.2.1 Asia Pacific Oral Contraceptive Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Contraceptive Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Contraceptive Market Size by Region
8.3.1 Asia Pacific Oral Contraceptive Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Contraceptive Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oral Contraceptive Market Size by Type
9.1.1 Latin America Oral Contraceptive Sales by Type (2017-2028)
9.1.2 Latin America Oral Contraceptive Revenue by Type (2017-2028)
9.2 Latin America Oral Contraceptive Market Size by Application
9.2.1 Latin America Oral Contraceptive Sales by Application (2017-2028)
9.2.2 Latin America Oral Contraceptive Revenue by Application (2017-2028)
9.3 Latin America Oral Contraceptive Market Size by Country
9.3.1 Latin America Oral Contraceptive Sales by Country (2017-2028)
9.3.2 Latin America Oral Contraceptive Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Contraceptive Market Size by Type
10.1.1 Middle East and Africa Oral Contraceptive Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Contraceptive Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Contraceptive Market Size by Application
10.2.1 Middle East and Africa Oral Contraceptive Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Contraceptive Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Contraceptive Market Size by Country
10.3.1 Middle East and Africa Oral Contraceptive Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Contraceptive Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Corporation Information
11.1.2 Pfizer, Inc. Overview
11.1.3 Pfizer, Inc. Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer, Inc. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer, Inc. Recent Developments
11.2 Bayer AG
11.2.1 Bayer AG Corporation Information
11.2.2 Bayer AG Overview
11.2.3 Bayer AG Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer AG Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer AG Recent Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Corporation Information
11.3.2 Merck & Co., Inc. Overview
11.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck & Co., Inc. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck & Co., Inc. Recent Developments
11.4 Janssen Global Services, LLC
11.4.1 Janssen Global Services, LLC Corporation Information
11.4.2 Janssen Global Services, LLC Overview
11.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Janssen Global Services, LLC Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Janssen Global Services, LLC Recent Developments
11.5 Mankind Pharma Ltd.
11.5.1 Mankind Pharma Ltd. Corporation Information
11.5.2 Mankind Pharma Ltd. Overview
11.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mankind Pharma Ltd. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mankind Pharma Ltd. Recent Developments
11.6 Teva Pharmaceutical Industries Ltd
11.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.6.2 Teva Pharmaceutical Industries Ltd Overview
11.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.7 Allergan, plc (Actavis)
11.7.1 Allergan, plc (Actavis) Corporation Information
11.7.2 Allergan, plc (Actavis) Overview
11.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Allergan, plc (Actavis) Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Allergan, plc (Actavis) Recent Developments
11.8 Piramal Enterprises Ltd.
11.8.1 Piramal Enterprises Ltd. Corporation Information
11.8.2 Piramal Enterprises Ltd. Overview
11.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Piramal Enterprises Ltd. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Piramal Enterprises Ltd. Recent Developments
11.9 Beijing Zizhu Pharm
11.9.1 Beijing Zizhu Pharm Corporation Information
11.9.2 Beijing Zizhu Pharm Overview
11.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Beijing Zizhu Pharm Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Beijing Zizhu Pharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Contraceptive Industry Chain Analysis
12.2 Oral Contraceptive Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Contraceptive Production Mode & Process
12.4 Oral Contraceptive Sales and Marketing
12.4.1 Oral Contraceptive Sales Channels
12.4.2 Oral Contraceptive Distributors
12.5 Oral Contraceptive Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Contraceptive Industry Trends
13.2 Oral Contraceptive Market Drivers
13.3 Oral Contraceptive Market Challenges
13.4 Oral Contraceptive Market Restraints
14 Key Findings in The Global Oral Contraceptive Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oral Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Combination
Table 3. Major Manufacturers of Progestin Only
Table 4. Major Manufacturers of Others
Table 5. Global Oral Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Oral Contraceptive Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Oral Contraceptive Sales by Region (2017-2022) & (K Units)
Table 8. Global Oral Contraceptive Sales Market Share by Region (2017-2022)
Table 9. Global Oral Contraceptive Sales by Region (2023-2028) & (K Units)
Table 10. Global Oral Contraceptive Sales Market Share by Region (2023-2028)
Table 11. Global Oral Contraceptive Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Oral Contraceptive Revenue Market Share by Region (2017-2022)
Table 13. Global Oral Contraceptive Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Oral Contraceptive Revenue Market Share by Region (2023-2028)
Table 15. Global Oral Contraceptive Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Oral Contraceptive Sales Share by Manufacturers (2017-2022)
Table 17. Global Oral Contraceptive Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Oral Contraceptive Revenue Share by Manufacturers (2017-2022)
Table 19. Oral Contraceptive Price by Manufacturers (2017-2022) &(USD/Unit)
Table 20. Global Oral Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Oral Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Contraceptive as of 2021)
Table 22. Oral Contraceptive Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Oral Contraceptive Product Offered
Table 24. Date of Manufacturers Enter into Oral Contraceptive Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 27. Global Oral Contraceptive Sales by Type (2023-2028) & (K Units)
Table 28. Global Oral Contraceptive Sales Share by Type (2017-2022)
Table 29. Global Oral Contraceptive Sales Share by Type (2023-2028)
Table 30. Global Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Oral Contraceptive Revenue Share by Type (2017-2022)
Table 33. Global Oral Contraceptive Revenue Share by Type (2023-2028)
Table 34. Oral Contraceptive Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Oral Contraceptive Price Forecast by Type (2023-2028) & (USD/Unit)
Table 36. Global Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 37. Global Oral Contraceptive Sales by Application (2023-2028) & (K Units)
Table 38. Global Oral Contraceptive Sales Share by Application (2017-2022)
Table 39. Global Oral Contraceptive Sales Share by Application (2023-2028)
Table 40. Global Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Oral Contraceptive Revenue Share by Application (2017-2022)
Table 43. Global Oral Contraceptive Revenue Share by Application (2023-2028)
Table 44. Oral Contraceptive Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Oral Contraceptive Price Forecast by Application (2023-2028) & (USD/Unit)
Table 46. North America Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 47. North America Oral Contraceptive Sales by Type (2023-2028) & (K Units)
Table 48. North America Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 51. North America Oral Contraceptive Sales by Application (2023-2028) & (K Units)
Table 52. North America Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 55. North America Oral Contraceptive Sales by Country (2023-2028) & (K Units)
Table 56. North America Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Oral Contraceptive Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 59. Europe Oral Contraceptive Sales by Type (2023-2028) & (K Units)
Table 60. Europe Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 63. Europe Oral Contraceptive Sales by Application (2023-2028) & (K Units)
Table 64. Europe Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 67. Europe Oral Contraceptive Sales by Country (2023-2028) & (K Units)
Table 68. Europe Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Oral Contraceptive Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Oral Contraceptive Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Oral Contraceptive Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Oral Contraceptive Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Oral Contraceptive Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Oral Contraceptive Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Oral Contraceptive Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Oral Contraceptive Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Oral Contraceptive Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Oral Contraceptive Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Oral Contraceptive Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Oral Contraceptive Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Oral Contraceptive Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Oral Contraceptive Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Oral Contraceptive Revenue by Country (2023-2028) & (US$ Million)
Table 106. Pfizer, Inc. Corporation Information
Table 107. Pfizer, Inc. Description and Major Businesses
Table 108. Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. Pfizer, Inc. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Pfizer, Inc. Recent Developments
Table 111. Bayer AG Corporation Information
Table 112. Bayer AG Description and Major Businesses
Table 113. Bayer AG Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. Bayer AG Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Bayer AG Recent Developments
Table 116. Merck & Co., Inc. Corporation Information
Table 117. Merck & Co., Inc. Description and Major Businesses
Table 118. Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Merck & Co., Inc. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Merck & Co., Inc. Recent Developments
Table 121. Janssen Global Services, LLC Corporation Information
Table 122. Janssen Global Services, LLC Description and Major Businesses
Table 123. Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. Janssen Global Services, LLC Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Janssen Global Services, LLC Recent Developments
Table 126. Mankind Pharma Ltd. Corporation Information
Table 127. Mankind Pharma Ltd. Description and Major Businesses
Table 128. Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. Mankind Pharma Ltd. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Mankind Pharma Ltd. Recent Developments
Table 131. Teva Pharmaceutical Industries Ltd Corporation Information
Table 132. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 133. Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Teva Pharmaceutical Industries Ltd Recent Developments
Table 136. Allergan, plc (Actavis) Corporation Information
Table 137. Allergan, plc (Actavis) Description and Major Businesses
Table 138. Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Allergan, plc (Actavis) Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Allergan, plc (Actavis) Recent Developments
Table 141. Piramal Enterprises Ltd. Corporation Information
Table 142. Piramal Enterprises Ltd. Description and Major Businesses
Table 143. Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 144. Piramal Enterprises Ltd. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Piramal Enterprises Ltd. Recent Developments
Table 146. Beijing Zizhu Pharm Corporation Information
Table 147. Beijing Zizhu Pharm Description and Major Businesses
Table 148. Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 149. Beijing Zizhu Pharm Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Beijing Zizhu Pharm Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Oral Contraceptive Distributors List
Table 154. Oral Contraceptive Customers List
Table 155. Oral Contraceptive Market Trends
Table 156. Oral Contraceptive Market Drivers
Table 157. Oral Contraceptive Market Challenges
Table 158. Oral Contraceptive Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Contraceptive Product Picture
Figure 3. Global Oral Contraceptive Market Share by Type in 2021 & 2028
Figure 3. Combination Product Picture
Figure 4. Progestin Only Product Picture
Figure 5. Others Product Picture
Figure 6. Global Oral Contraceptive Market Share by Application in 2021 & 2028
Figure 7. Male
Figure 8. Female
Figure 9. Oral Contraceptive Report Years Considered
Figure 10. Global Oral Contraceptive Sales 2017-2028 (K Units)
Figure 11. Global Oral Contraceptive Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Oral Contraceptive Revenue 2017-2028 (US$ Million)
Figure 13. Global Oral Contraceptive Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Oral Contraceptive Sales Market Share by Region (2017-2022)
Figure 15. Global Oral Contraceptive Sales Market Share by Region (2023-2028)
Figure 16. North America Oral Contraceptive Sales YoY (2017-2028) & (K Units)
Figure 17. North America Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Oral Contraceptive Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Oral Contraceptive Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Oral Contraceptive Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Oral Contraceptive Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Oral Contraceptive Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Oral Contraceptive in the World: Market Share by Oral Contraceptive Revenue in 2021
Figure 28. Global Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Oral Contraceptive Sales Market Share by Type (2017-2028)
Figure 30. Global Oral Contraceptive Revenue Market Share by Type (2017-2028)
Figure 31. Global Oral Contraceptive Sales Market Share by Application (2017-2028)
Figure 32. Global Oral Contraceptive Revenue Market Share by Application (2017-2028)
Figure 33. North America Oral Contraceptive Sales Market Share by Type (2017-2028)
Figure 34. North America Oral Contraceptive Revenue Market Share by Type (2017-2028)
Figure 35. North America Oral Contraceptive Sales Market Share by Application (2017-2028)
Figure 36. North America Oral Contraceptive Revenue Market Share by Application (2017-2028)
Figure 37. North America Oral Contraceptive Sales Share by Country (2017-2028)
Figure 38. North America Oral Contraceptive Revenue Share by Country (2017-2028)
Figure 39. U.S. Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Oral Contraceptive Sales Market Share by Type (2017-2028)
Figure 42. Europe Oral Contraceptive Revenue Market Share by Type (2017-2028)
Figure 43. Europe Oral Contraceptive Sales Market Share by Application (2017-2028)
Figure 44. Europe Oral Contraceptive Revenue Market Share by Application (2017-2028)
Figure 45. Europe Oral Contraceptive Sales Share by Country (2017-2028)
Figure 46. Europe Oral Contraceptive Revenue Share by Country (2017-2028)
Figure 47. Germany Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 48. France Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Oral Contraceptive Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Oral Contraceptive Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Oral Contraceptive Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Oral Contraceptive Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Oral Contraceptive Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Oral Contraceptive Revenue Share by Region (2017-2028)
Figure 58. China Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 61. India Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Oral Contraceptive Sales Market Share by Type (2017-2028)
Figure 69. Latin America Oral Contraceptive Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Oral Contraceptive Sales Market Share by Application (2017-2028)
Figure 71. Latin America Oral Contraceptive Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Oral Contraceptive Sales Share by Country (2017-2028)
Figure 73. Latin America Oral Contraceptive Revenue Share by Country (2017-2028)
Figure 74. Mexico Oral Contraceptive Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Or

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......

Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......

Global Contraceptives Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141

According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......

Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......

Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......

Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139

Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122

Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......

Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......

Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs